Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharma Konsult Skåne AB
AB
Active
Org 5594269630
Östgötagatan 5, 262 43
Ängelholm
Retail sale of pharmaceutical products
· NACE 4773
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Pharma Konsult Skåne AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
151
233
Staff expenses
−142
−155
EBITDA
−69
50
Depreciation & amort.
—
—
EBIT
−69
50
Net financials
0
−0
Profit before tax
−69
50
Tax
—
—
Net profit
−69
50
Balance sheet
SEK thousands
Item
2024
2025
Total assets
52
6
Equity
−44
6
Long-term debt
—
—
Short-term debt
96
0
Total debt
96
—
Financial ratios
5-year trend
EBITDA margin
21.4%
This company
15.8%
Market median
+35% vs market
2024
2025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2024
2025
Return on equity
887.6%
This company
18.4%
Market median
+4724% vs market
2024
2025
Net profit margin
21.2%
This company
8.1%
Market median
+162% vs market
2024
2025
Asset turnover
41.80×
This company
1.12×
Market median
+3632% vs market
2024
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-03-20 – 2024-03-31
View
PDF
More on Pharma Konsult Skåne AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
